Operational planning

The NBA has established a comprehensive three year planning framework (2013-16) as depicted in Figure 3.2. The NBA Operational Plan outlines the supporting work programme for the second year of this framework and is structured to align with the goals and objectives identified in the approved JBC Strategic Plan 2013-15 and NBA Corporate Plan 2013-16. Other key documents the work programme takes into account include:

• JBC-approved National Blood Sector Data and Information Strategy and Scorecard 2013-2016
• JBC-approved National Blood Sector ICT Strategy 2013-2016
• JBC-approved National Blood and Blood Product Wastage Reduction Strategy 2013-2017
• JBC-approved National Patient Blood Management Guidelines Implementation Strategy 2013-2017
• National Blood Sector Education and Training Strategy 2013-2016
• NBA Risk Management Register
• Research and Development Statement of Priorities 2013-16.

Progress against the Operational Plan is monitored and reported on by Executive Members and the General Manager on a quarterly basis. The quarterly report on progress against key actions is provided to the NBA Board and Audit Committee

FIGURE 3.2 NBA Planning Framework

In 2014-15, the NBA delivered 91 per cent of activities against the planned outcomes. Table 3.1 demonstrates the overall trend in the NBA's delivery against our operational plans over the past four years.

TABLE 3.1 NBA's performance in achieving operational plan objectives, 2011–12 to 2014–15

Key operational achievements for 2014-15 included the following:

• the uninterrupted supply of blood and blood products to meet all clinical demand in accordance with the approved NSP&B
• the development and implementation of a health provider Charter requiring a formal commitment at a CEO level to measures that improve the management and use of blood and blood products
• the publication of national PBM Guidelines Module 5 on Obstetrics and Maternity and development of Module 6 on Neonatal and Paediatrics for release early in 2016
• the publication and implementation of new Ig Governance policies, a standardised patient treatment review process and revised forms
• review of the Criteria for the clinical use of intravenous immunoglobulin in Australia (Criteria) for adaptation to the new information management system under development, BloodSTAR
• the successful conclusion of a tender process for new contracts for the national supply of imported Ig to replace the current contracts which expire on 31 December 2015, are projected to achieve annual savings in the order of $30 million per year
• publication of a range of data reports including the Report on the Issue and Use of Intravenous Immunoglobulin (IVIg) 2013-14, Strategic Framework for the National Haemovigilance Program and the Australian Bleeding Disorders Registry Annual Report 2013-14
• the 2015 National Blood Symposium, held in Brisbane to support Australian health providers to implement the National Safety and Quality Health Service Standard 7 on Blood and Blood Products.

2015–16 Operational Plan

The NBA finalised the 2015-16 operational plan in June 2015. The plan outlines the supporting work programme for the final year of the three year planning framework.